All Relations between Dyskinesias and dopamine

Publication Sentence Publish Date Extraction Date Species
D B Calne, K Burton, J Beckman, W R Marti. Dopamine agonists in Parkinson's disease. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques. vol 11. issue 1 Suppl. 1984-05-29. PMID:6231979. the tangible clinical benefit of dopamine agonists has been evident in patients with prominent dyskinesia or wearing off reactions. 1984-05-29 2023-08-12 Not clear
R Neale, S Gerhardt, J M Liebma. Effects of dopamine agonists, catecholamine depletors, and cholinergic and GABAergic drugs on acute dyskinesias in squirrel monkeys. Psychopharmacology. vol 82. issue 1-2. 1984-03-16. PMID:6320248. effects of dopamine agonists, catecholamine depletors, and cholinergic and gabaergic drugs on acute dyskinesias in squirrel monkeys. 1984-03-16 2023-08-12 monkey
B Zivkovic, B Scatton, P Worms, K G Lloyd, G Bartholin. Pharmacological and therapeutic actions of GABA receptor agonists. Journal of neural transmission. Supplementum. vol 18. 1983-09-20. PMID:6308150. the antagonism of the neuroleptic-induced increase in dopamine receptor sensitivity and the decrease in dopamine synthesis and release may be responsible for the effectiveness of the gaba receptor agonists in the treatment of neuroleptic- and l-dopa-induced dyskinesia. 1983-09-20 2023-08-12 Not clear
J Jankovi. Management of motor side effects of chronic levodopa therapy. Clinical neuropharmacology. vol 5 Suppl 1. 1982-12-02. PMID:7116343. levodopa-induced dyskinesias are thought to be due to striatal dopamine-receptor hypersensitivity as a result of chronic and excessive dopamine agonism. 1982-12-02 2023-08-12 Not clear
M Goldstein, A Lieberman, J Pearso. Relatively high levels of dopamine in nucleus accumbens of levodopa treated patients with Parkinson's disease. Journal of neural transmission. vol 54. issue 1-2. 1982-10-29. PMID:6125563. the relatively high dopamine levels in the nucleus accumbens may be responsible for the occurrence of dyskinesias. 1982-10-29 2023-08-12 Not clear
J C Aschoff, D Claus, W D Hetze. [Tiapride therapy of centrally produced dyskinesia. Examination of the serum levels of protein, LH and FSH (author's transl)]. Arzneimittel-Forschung. vol 32. issue 3. 1982-07-08. PMID:6805485. the effect of n-(2-diethylaminoethyl)-2-methoxy-5-(methylsulfonyl)-benzamide hydrochloride (tiapride, tiapridex), a dopamine antagonist, on the serum levels of prolactin, luteinising hormone (lh) and follicle-stimulating hormone (fsh) was studied on 20 healthy individuals and 10 patients with dyskinesia resulting from extrapyramidal disorders. 1982-07-08 2023-08-12 human
C Strozzi, G Cocco, S Christelle. [Evaluation of coronary heart disease by kinetocardiography and electrocardiography before and after injection of dopamine and isoproterenol]. Archivos del Instituto de Cardiologia de Mexico. vol 51. issue 1. 1981-05-26. PMID:7212862. the infusion of dopamine or isoproterenol induces dyskinesia in some patients with coronary insufficiency. 1981-05-26 2023-08-12 human
R J Baldessarini, D Tars. Dopamine and the pathophysiology of dyskinesias induced by antipsychotic drugs. Annual review of neuroscience. vol 3. 1980-11-24. PMID:6106450. dopamine and the pathophysiology of dyskinesias induced by antipsychotic drugs. 1980-11-24 2023-08-12 Not clear
T Ashizawa, B M Patten, J Jankovi. Meige's syndrome. Southern medical journal. vol 73. issue 7. 1980-08-28. PMID:7384844. we think that biochemical abnormalities in the basal ganglia are responsible for the dyskinesias and submit data suggesting a reduction of dopamine turnover in the central nervous system of one patient. 1980-08-28 2023-08-12 Not clear
A J Lees, C M Lander, G M Ster. Tiapride in levodopa-induced involuntary movements. Journal of neurology, neurosurgery, and psychiatry. vol 42. issue 4. 1979-09-25. PMID:458486. these results fail to support the notion that levodopa-induced dyskinesias are caused by overstimulation of a separate group of dopamine receptors. 1979-09-25 2023-08-11 Not clear
G Roccatagliata, C Albano, G Besi. [Late chronic dyskinesia from neuroleptic drugs (CSF and pharmacological data) (author's transl)]. Rivista di patologia nervosa e mentale. vol 98. issue 4. 1979-04-28. PMID:33440. csf values of dopamine and serotonine metabolites (homovanillic acid and 5-hydroxy-indoleacetic acid) have been studied in 4 patients suffering from late dyskinesia due to neuroleptics. 1979-04-28 2023-08-11 Not clear
P Bédard, J D Parkes, C D Marsde. Effect of new dopamine-blocking agent (oxiperomide) on drug-induced dyskinesias in Parkinson's disease and spontaneous dyskinesias. British medical journal. vol 1. issue 6118. 1978-06-17. PMID:638546. oxiperomide, a new dopamine-receptor antagonist, was found to decrease dyskinesias in patients with parkinson's disease receiving levodopa or other dopamine agonists without necessarily increasing parkinsonian symptoms. 1978-06-17 2023-08-11 Not clear
A Villeneuve, P Langlier, P Bédar. Estrogens, dopamine and dyskinesias. Canadian Psychiatric Association journal. vol 23. issue 1. 1978-06-12. PMID:205334. estrogens, dopamine and dyskinesias. 1978-06-12 2023-08-11 Not clear
K R Carlson, R D Eiberge. Susceptibility to amphetamine-elicited dyskinesias following chronic methadone treatment in monkeys. Annals of the New York Academy of Sciences. vol 281. 1977-04-15. PMID:828468. they immediately exhibited oral dyskinesias resembling the symptoms of tardive dyskinesia in humans, a condition resulting from chronic blockade of striatal dopamine receptors by neuroleptics. 1977-04-15 2023-08-11 monkey
K R Carlson, R D Eiberge. Susceptibility to amphetamine-elicited dyskinesias following chronic methadone treatment in monkeys. Annals of the New York Academy of Sciences. vol 281. 1977-04-15. PMID:828468. following treatment, stimulation of hypersensitive striatal receptors by the dopamine released by ma results in oral dyskinesias. 1977-04-15 2023-08-11 monkey
D Chadwick, E H Reynolds, C D Marsde. Anticonvulsant-induced dyskinesias: a comparison with dyskinesias induced by neuroleptics. Journal of neurology, neurosurgery, and psychiatry. vol 39. issue 12. 1977-03-31. PMID:1011032. these dyskinesias are similar to those caused by neuroleptic drugs and may be related to dopamine antagonistic properties possessed by dph. 1977-03-31 2023-08-11 Not clear
R E Dill, W L Davis, I Thonnard-Phillip. Motor disturbances produced by intrastriatal injection of cyclic AMP and cyclic GMP. Archives internationales de pharmacodynamie et de therapie. vol 224. issue 1. 1977-03-21. PMID:189712. the concomitant intrastriatal injection of dopamine and carbachol resulted in a blockade of the carbachol-induced dyskinesias. 1977-03-21 2023-08-11 rat
J Korein, J Brudn. Integrated EMG feedback in the management of spasmodic torticollis and focal dystonia: a prospective study of 80 patients. Research publications - Association for Research in Nervous and Mental Disease. vol 55. 1977-02-24. PMID:1087448. naturally, the specific finding of a defective transmitter agent (e.g., gaba) such as described in parkinsonian syndrome (dopamine) or the interruption of a specific pathway that causes and improves a dyskinesia is desirable. 1977-02-24 2023-08-11 Not clear
R D Eibergen, K R Carlso. Dyskinesias in monkeys: interaction of methamphetamine with prior methadone treatment. Pharmacology, biochemistry, and behavior. vol 5. issue 2. 1977-01-25. PMID:825885. they immediately developed oral dyskinesias resembling the symptoms of tardive dyskinesia in humans, a condition resulting from chronic blockade of striatal dopamine receptors by neuroleptics. 1977-01-25 2023-08-11 monkey
B Costall, R J Naylo. Dissociation of stereotyped biting responses and oro-bucco-lingual dyskinesias. European journal of pharmacology. vol 36. issue 2. 1976-08-23. PMID:945168. failed to modify the dyskinesias induced by intrastriatal dopamine. 1976-08-23 2023-08-11 Not clear